Hepatocellular carcinoma is the condition characterized by cancer in the liver. This is the most common primary liver cancer. Men are more affected by this cancer as compared to women. People with chronic liver conditions such as liver cirrhosis are most commonly develop liver cancer. People with excessive intake of alcohol and deposition of fat in the liver are more prone to develop this cancer. The diagnosis of liver cancer is done through various techniques including imaging techniques such as CT scan or MRI, blood tests to evaluate the liver function and liver biopsy to have conclusive evidence of liver cancer. Treatment includes chemotherapy, radiotherapy, immunotherapy, target therapy, surgery, and liver transplant. As the liver is the major organ that takes part in the digestion process, the symptoms experienced by the patient are generally related to GIT. The symptoms include abdominal pain, swelling in the abdomen, weight loss, loss of appetite and yellow discoloration of eyes. Liver cancer has a poor prognosis with a five-year survival rate of 28% when the cancer is confined to the liver. When spread to other organs, the five-year survival rate is just 7%.

PATIENT INTRODUCTION AND MEDICAL CONDITION

51-year-old Nizammudin, a citizen of Pakistan, was diagnosed with liver cancer. The positive part was that his cancer was confined within the liver and has not spread to other organs. He was complaining of indigestion and pain and the risk of liver failure was high. He was on the medicines and had already undergone Transarterial chemoembolization. In this process, some of the arteries of the liver are blocked so that in the absence of the blood supply, the cancer cells die. However, Transarterial chemoembolization was unsuccessful in curing cancer as his alpha-fetoprotein (AFP) levels were not under control.

TREATMENT DECISION

Local doctor suggested him to undergo liver transplantation. He searched for some of the best places in the world where the liver transplant is done with a high success rate at an affordable price. During his search, he came to know about MediGence, which is one of the best medical tourism service providers across the globe. Nizamuddin approach Medigence and immediately the team came into action. MediGence team provided options for Liver Transplant and the patient opted to get it done from Dr. Subhash Gupta of Max Super Specialty Hospital, Saket, New Delhi. The patient arrived in India on 25th February 2019.

Recovery

After analyzing the previous reports and performing further evaluation tests, Dr. Subhash Gupta decided to perform Transarterial chemoembolization to bring down the Alpha-fetoprotein level prior to a liver transplant.  Although he has to wait for 3 weeks after Transarterial chemoembolization to reduce the AFP at the optimum level, the wait was worth as his AFP was reduced to the required level. The transplant was done by using a part of the liver of his own son. Team Medigence works tirelessly to provide the best service to Nizamuddin by assisting him in securing a visa, preparing documents, arranging for medications, and prior appointment with the doctors. Team MediGence wish him a speedy recovery and cancer-free health ahead.